Xi'an International Medical Investment Company Limited (000516.SZ) has a MoatMap StockRank of 22/100 based on Quality (28/100), Value (36/100), and Momentum (44/100) factor scores. The current signal is SELL. Xi'an International Medical operates hospital services in China. It is a highly capital-intensive business subject to strict domestic regulatory oversight and lacks the asset-light, high-ROIC profile required for our concentrated portfolio.
Xi'an International Medical Investment is a leading private healthcare services provider in Western China, operating large-scale, modern medical institutions including the Xi'an International Medical Center. The company differentiates itself through high-end medical equipment, top-tier clinical talent, and a comprehensive, multi-disciplinary healthcare ecosystem. It is well-positioned to benefit from China's growing demand for premium, private healthcare services.
| Price | $0.57 |
| Market Cap | $1.4B |
| P/E (Forward) | 31.85 |
| Price/Book | 2.84 |
| Return on Equity | -11.5% |
| Return on Invested Capital | -5.0% |
| Debt/Equity | 146.05 |
| Gross Margin | 8.9% |
| Operating Margin | -4.2% |
| Revenue Growth | -2.8% |
| Free Cash Flow | $9M |
Xi'an International Medical Investment Company Limited operates in the Medical Care Facilities industry, part of the Healthcare sector (China).